Philippe Gaulard

Q: What Schools Are Affiliated With Philippe Gaulard

Philippe Gaulard is affiliated with the following schools: University of Leicester, Normandy University Group, Université Paris Cité, Paris Diderot University

Philippe Gaulard's AcademicInfluence.com Rankings

Philippe Gaulard

Philosophy

#6532

World Rank

#9581

Historical Rank

Logic

#3685

World Rank

#4881

Historical Rank

philosophy Degrees

Philippe Gaulard

Biology

#8865

World Rank

#12002

Historical Rank

Pathology

#117

World Rank

#232

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Philippe Gaulard's Degrees

PhD Pathology Université Paris Cité
Doctorate Medicine Université Paris Cité

Why Is Philippe Gaulard Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Philippe Gaulard's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. (2002) (2551)
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. (2005) (1312)
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma (2003) (1074)
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases (2002) (586)
Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). (2003) (538)
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. (2007) (528)
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). (1998) (503)
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. (2005) (501)
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA). (1996) (484)
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study. (2000) (453)
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. (2012) (436)
Prognostic significance of survivin expression in diffuse large B-cell lymphomas. (2000) (417)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. (2012) (386)
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. (2011) (384)
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. (2012) (381)
Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients (2003) (377)
Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. (1993) (353)
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. (2011) (330)
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. (1997) (304)
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells (2015) (303)
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. (2008) (299)
Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. (1990) (288)
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. (2010) (282)
A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response (2002) (282)
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 (2007) (275)
Mediastinal Gray Zone Lymphoma: The Missing Link Between Classic Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma (2005) (272)
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. (2011) (263)
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium. (2007) (240)
Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL): A New Diagnostic Marker Providing Evidence That AITL Derives From Follicular Helper T Cells (2006) (230)
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936 (2007) (225)
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. (2016) (221)
Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. (1995) (221)
Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma (2010) (218)
CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. (1996) (215)
Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. (1996) (211)
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. (2003) (204)
Nonhepatosplenic γδ T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization (1998) (201)
Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. (2004) (200)
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study. (2015) (197)
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. (2007) (195)
Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. (1994) (194)
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. (2011) (194)
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. (1997) (187)
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. (2016) (185)
Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (2008) (179)
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). (1999) (175)
Histologic Evolution of Angioimmunoblastic T-cell Lymphoma in Consecutive Biopsies: Clinical Correlation and Insights Into Natural History and Disease Progression (2007) (172)
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma (2014) (170)
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. (2006) (169)
The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. (2022) (165)
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. (2013) (164)
Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas. (1990) (159)
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas (2006) (157)
Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials. (2012) (156)
Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma (2003) (156)
MONOCLONAL ANTIBODY (HML-1) REACTIVITY OF T-CELL LYMPHOMAS (1989) (154)
Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand (2004) (154)
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. (2003) (153)
Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas (2009) (153)
Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells (2012) (151)
Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodgkin's Lymphoma (1996) (150)
Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. (2006) (150)
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. (2013) (149)
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation. (2012) (148)
Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015) (147)
L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. (2009) (146)
Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. (2007) (143)
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients. (2003) (142)
Expression of the bcl-2 gene product in follicular lymphoma. (1992) (142)
Pyothorax-Associated Lymphoma: A Peculiar Clinicopathologic Entity Derived From B Cells at Late Stage of Differentiation and With Occasional Aberrant Dual B- and T-Cell Phenotype (2002) (140)
The Genetic Basis of Hepatosplenic T-cell Lymphoma. (2017) (140)
Primary lymphoma of the liver: Clinical‐pathological features and relationship with HCV infection in French patients (2003) (139)
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma (2014) (138)
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. (2017) (135)
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. (2019) (135)
Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. (2006) (134)
Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network. (2017) (133)
MAL Expression in Lymphoid Cells: Further Evidence for MAL as a Distinct Molecular Marker of Primary Mediastinal Large B-Cell Lymphomas (2002) (132)
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations (2016) (129)
Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. (1995) (129)
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis (2009) (129)
Peripheral T‐cell and NK‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology (2014) (127)
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin (2017) (126)
The MAL gene is expressed in primary mediastinal large B-cell lymphoma. (1999) (125)
Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. (2004) (124)
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium. (2019) (123)
Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. (1999) (122)
Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study. (2009) (122)
Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients (2002) (121)
Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial (2013) (117)
Presence of HTLV‐I proviral DNA in patients with adult T‐Cell leukemia/lymphoma in Taiwan (1988) (116)
Survival and Clonal Expansion of Mutating “Forbidden” (Immunoglobulin Receptor–Deficient) Epstein-Barr Virus–Infected B Cells in Angioimmunoblastic T Cell Lymphoma (2001) (115)
Erythroblasts are a source of angiogenic factors. (2001) (113)
Hepatosplenic and other γδ T-cell lymphomas (2007) (109)
Nonhepatosplenic &ggr;&dgr; T-cell Lymphomas Represent a Spectrum of Aggressive Cytotoxic T-cell Lymphomas With a Mainly Extranodal Presentation (2011) (106)
Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. (2018) (106)
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome (2001) (104)
Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma. (2009) (103)
VJ REARRANGEMENTS OF THE TCRγ LOCUS IN PERIPHERAL T‐CELL LYMPHOMAS: ANALYSIS BY POLYMERASE CHAIN REACTION AND DENATURING GRADIENT GEL ELECTROPHORESIS (1996) (103)
p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas. (2002) (102)
Activating mutations of STAT5B and STAT3 in lymphomas derived from gamma delta-T or NK cells (102)
Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. (2005) (101)
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. (1998) (100)
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab (2008) (98)
Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T‐cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression (2002) (97)
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma (2009) (97)
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation (2010) (95)
Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. (2012) (94)
Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. (1994) (93)
Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas (2003) (93)
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers (2017) (93)
Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels. (2014) (92)
Necrotizing vasculitis and HIV replication in peripheral nerves. (1989) (92)
Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. (1994) (92)
Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. (2000) (92)
Primary breast non‐Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors (2009) (91)
Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. (2003) (87)
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL). (2016) (86)
Cytotoxic protein expression in natural killer cell lymphomas and in αβ and γδ peripheral T‐cell lymphomas (1997) (86)
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets (2015) (86)
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation (1999) (85)
Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen. (1990) (85)
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas (2019) (84)
Follicular helper T cells: implications in neoplastic hematopathology. (2011) (82)
Peripheral T‐cell lymphoma presenting as predominant liver disease: A report of three cases (1986) (81)
Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma (2017) (81)
Peripheral T/NK‐cell lymphoma: a report of the IXth Workshop of the European Assocation for Haematopathology (2001) (81)
Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. (1999) (81)
Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics (2002) (80)
Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma. (1987) (80)
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas (2005) (80)
The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development (2016) (79)
Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma (2016) (77)
T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts. (2001) (77)
Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma. (2003) (76)
Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. (1998) (76)
Bone Marrow Involvement in Lymphomas With Hemophagocytic Syndrome at Presentation: A Clinicopathologic Study of 11 Patients in a Western Institution (2001) (76)
Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA (2012) (75)
The mutator pathway is a feature of immunodeficiency-related lymphomas. (2004) (75)
Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry. (2019) (74)
Molecular classification of T-cell lymphomas. (2009) (73)
Cytotoxic T-cell and NK-cell Lymphomas: Current Questions and Controversies (2014) (73)
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. (2007) (73)
Impact of high-dose chemotherapy on peripheral T-cell lymphomas. (2002) (72)
Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics (2012) (71)
T‐Cell lymphoma revealed by a peripheral neuropathy: A report of two cases with an immunohistologic study on lymph node and nerve biopsies (1986) (71)
Recombination pattern of the TCR γ locus in human peripheral T‐cell lymphomas (1994) (70)
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. (2019) (70)
Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus. (2008) (69)
Immunohistological detection of human cytotoxic/suppressor T cells using antibodies to a CD8 peptide sequence. (1992) (69)
Primary mediastinal (thymic) large B-cell lymphoma (2008) (69)
Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. (2012) (68)
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages (2009) (68)
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases. (2000) (67)
A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response (2003) (67)
Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell Lymphoma (2015) (67)
Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? (2005) (66)
Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients (2014) (66)
DNMT3AR882H mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice (2016) (66)
Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. (1997) (65)
Hepatosplenic αβ T-cell lymphoma : An unusual case with clinical, histologic, and cytogenetic features of γδ hepatosplenic T-cell lymphoma (2000) (64)
Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate (2009) (64)
Molecular underpinning of extranodal NK/T-cell lymphoma. (2013) (62)
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features (2013) (62)
HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms. (2013) (61)
Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: A study of 38 cases. (1991) (59)
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. (2003) (58)
T-Cell Lymphomas (2003) (58)
Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. (1995) (57)
High total metabolic tumor volume at baseline predicts survival independent of response to therapy (2020) (57)
Low grade B cell mucosa associated lymphoid tissue lymphoma of the stomach: clinical and endoscopic features, treatment, and outcome. (1992) (57)
Hepatosplenic and other gammadelta T-cell lymphomas. (2007) (56)
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium (2014) (56)
Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein–Barr virus infection. A different subtype of AILD-TL? (2002) (54)
Mediastinal Diffuse Large‐Cell Lymphoma with Sclerosis: A Condition with a Poor Prognosis (1989) (54)
Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder. (1988) (54)
Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de Moelle. (1999) (54)
Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype (2008) (53)
Pathology and biology of peripheral T‐cell lymphomas (2011) (51)
De novo acute B cell leukemia/lymphoma with t(14;18) (2000) (51)
Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin‐embedded lymphoma biopsy samples (2003) (51)
CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells. (2015) (50)
Pathobiology of Primary Mediastinal B-Cell Lymphoma (2003) (50)
Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study. (2004) (50)
Pathology of peripheral T-cell lymphomas: where do we stand? (2014) (49)
Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis? (2014) (49)
Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man. (2009) (49)
Sjögren's syndrome and cutaneous B cell lymphoma revealed by anetoderma. (1993) (49)
STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model (2013) (48)
Efficacy of 5‐Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma (2015) (48)
Characterization of CXCL13+ Neoplastic T Cells in Cutaneous Lesions of Angioimmunoblastic T-cell Lymphoma (AITL) (2007) (48)
The microenvironment in T-cell lymphomas: emerging themes. (2014) (48)
T Cell Receptor Genotyping and HOXA/TLX1 Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome (2008) (47)
Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5‐Azacytidine (2014) (45)
Intraepidermal localization of the clone in cutaneous T-cell lymphoma. (1992) (45)
Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas. (1998) (43)
Comparison of genetic probe with immunophenotype analysis in lymphoproliferative disorders: a study of 87 cases. (1988) (43)
Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas. (1991) (43)
Pathobiology and molecular profiling of peripheral T-cell lymphomas. (2008) (43)
A novel genetic thrombocytopenia (Paris-Trousseau) associated with platelet inclusions, dysmegakaryopoiesis and chromosome deletion AT 11q23. (1993) (42)
Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. (2020) (42)
BCL2 gene activation and protein expression in follicular lymphoma: a report on 64 cases. (1993) (41)
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. (2012) (40)
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium (2017) (40)
The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations (2019) (39)
CD10 expression in diffuse large B-cell lymphomas does not influence survival (2004) (39)
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial (2020) (39)
Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up (2010) (39)
Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice. (2012) (39)
Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond (2016) (38)
High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP. (2020) (38)
Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. (1995) (37)
Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations. (2001) (37)
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA) (2021) (37)
Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. (1993) (36)
Pathologic and Clinical Features of 77 Hodgkin's Lymphoma Patients Treated in a Lymphoma Protocol (LNH87): A GELA Study (2001) (36)
EPSTEIN–BARR VIRUS IN NON‐HODGKIN'S LYMPHOMAS OF THE UPPER RESPIRATORY TRACT: ASSOCIATION WITH SINONASAL LOCALIZATION AND EXPRESSION OF NK AND/OR T‐CELL ANTIGENS BY TUMOUR CELLS (1996) (36)
Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature. (2013) (35)
Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. (1997) (35)
Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas (1998) (35)
Epstein‐Barr Virus (EBV) Genomes and EBV‐Encoded Latent Membrane Protein (LMP) in Pulmonary Lymphomas Occurring in Nonimmunocompromised Patients (1993) (35)
Hepatosplenic T-Cell Lymphoma (2019) (35)
Primary cutaneous follicular variant of peripheral T‐cell lymphoma NOS. A report of two cases (2010) (34)
Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma. (2006) (34)
Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. (1996) (34)
CD30+ lymphoproliferative disorders (2010) (34)
New insights into breast implant-associated anaplastic large cell lymphoma (2018) (34)
Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment. (2001) (33)
Interleukin-2 and interferon-gamma production in follicular lymphomas. (1991) (33)
Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial. (2017) (33)
Expression of the bcl-2 protein in B cell lymphomas arising from mucosa associated lymphoid tissue. (1995) (32)
Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3−/dimCD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic (2016) (32)
Early lesions in lymphoid neoplasia (2012) (30)
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups (2013) (30)
Primary lymphoma of the liver. (2008) (30)
Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients (2016) (29)
Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation. (2018) (29)
Treatment with Hypomethylating Agent 5-Azacytidine Induces Sustained Response in Angioimmunoblastic T Cell Lymphomas (2016) (29)
Increased expression of interleukin-4 during liver allograft rejection. (1999) (27)
Interleukin‐7 receptor expression in cutaneous T‐cell lymphomas (1996) (27)
In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study (2004) (27)
GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism. (2019) (27)
Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. (2010) (27)
Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas. (1996) (27)
In situ detection of activated cytotoxic cells in follicular lymphomas. (1994) (27)
Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma. (2007) (27)
Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations (2015) (26)
Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 cases (1997) (26)
Mucosa-associated lymphoid tissue lymphoma of the thymus: a case report with no evidence of MALT1 rearrangement (2005) (26)
A phase II study of bortezomib in combination with intensified CHOP-like regimen (ACVBP) in patients with previously untreated T-cell lymphoma: Results of the GELA LNH05-1T trial. (2016) (26)
Lymphomatoid granulomatosis in a patient with acute myeloblastic leukemia in remission (1990) (25)
Gammadelta T-cell lymphomas. (2003) (25)
Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma. (2000) (25)
Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study (2008) (25)
Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression. (2005) (24)
c‐Maf expression in angioimmunoblastic T‐cell lymphoma reflects follicular helper T‐cell derivation rather than oncogenesis (2012) (24)
Extranodal NK/T-Cell Lymphoma: Toward the Identification of Clinical Molecular Targets (2011) (24)
R-ICE Versus R-DHAP in Relapsed Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Followed by Stem Cell Transplantation and Maintenance Treatment with Rituximab or Not: First Interim Analysis on 200 Patients. CORAL Study. (2007) (23)
Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 cases (2008) (23)
Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft. (2000) (22)
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma (2005) (22)
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma. (2021) (22)
New insights in the pathogenesis of T-cell lymphomas (2018) (22)
Final Analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): Romidepsin Plus CHOP in Patients with Peripheral T-Cell Lymphoma (2020) (21)
CD1d-restricted peripheral T cell lymphoma in mice and humans (2016) (21)
Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T‐cell lymphoma (2019) (21)
Systemic mastocytosis following mediastinal germ cell tumor: an association confirmed. (1993) (21)
RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells (2018) (21)
ALK-negative anaplastic large-cell lymphoma. (2016) (21)
Rituximab in Combination with CHOP Regimen in Angioimmunoblastic T-Cell Lymphoma (AITL). Preliminary Results in 9 Patients Treated in a Single Institution. (2005) (21)
Carpal tunnel syndrome due to T cell lymphoma. (1995) (20)
Cellular origin of T-cell lymphomas. (2014) (20)
Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (pTNHL) of the elderly: Final results of 116 patients treated in the international ACT-2 phase III trial. (2016) (20)
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. (1999) (20)
Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trial. (2012) (20)
Epstein–Barr virus‐associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone (2002) (20)
The mechanisms underlying MMR deficiency in immunodeficiency‐related non‐Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms (2009) (20)
Recombination pattern of the TCR gamma locus in human peripheral T-cell lymphomas. (1994) (20)
Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas (2017) (20)
Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing. (2018) (20)
New biomarkers in T-cell lymphomas. (2012) (19)
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma. (1998) (19)
Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas (2017) (19)
BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial (2017) (19)
[Epithelial-myoepithelial carcinoma of the salivary glands. Study of 15 cases and review of the literature]. (1991) (19)
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies (2018) (19)
Hepatosplenic T cell lymphoma responsive to 2′‐deoxycoformycin therapy (2010) (18)
First Analysis of an International Double-Blind Randomized Phase III Study of Lenalidomide Maintenance in Elderly Patients with DLBCL Treated with R-CHOP in First Line, the Remarc Study from Lysa (2016) (18)
A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL. (2020) (18)
Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms. (2022) (17)
Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay (2019) (17)
Sarcomatoid variant of anaplastic large cell lymphoma mimics ALK-1-positive inflammatory myofibroblastic tumor in bladder. (2005) (17)
Clinical and biological analysis of peripheral T-cell lymphomas: a single institution study. (1992) (17)
Hairy Cell Leukemia Associated With Large Granular Lymphocyte Leukemia: Immunologic and Genomic Study, Effect of Interferon Treatment (1988) (17)
Primary thrombocythaemia associated with systemic mastocytosis: a report of five cases (1991) (17)
Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma. (2016) (17)
Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology (2006) (17)
Hepatosplenic T-cell Lymphoma : Sinusal / Sinusoidal Localization of Malignant Cells Expressing the T-cell Receptor y 6 (2003) (17)
Primary Hepatic Lymphoma of Mucosa-Associated Lymphoid Tissue Type: A Case Report With Cytogenetic Study (2008) (16)
Cutaneous pseudolymphomas: immunophenotypical and immunogenotypical studies. (1989) (16)
Peripheral T cell lymphoma with Sjögren's syndrome: a report with immunologic and genotypic studies. (1991) (16)
Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation. (1997) (16)
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified (2021) (16)
FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP) (2004) (16)
Protein‐Losing Enteropathy in Gastrointestinal Sarcoidosis Associated with Malignant Lymphoma (1992) (15)
Prognostic Factors and Long Term Outcome of 138 Adults with Systemic Anaplastic Large-Cell Lymphoma: a Retrospective Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA) (2010) (15)
Activating mutations of STAT 5 B and STAT 3 in lymphomas derived from gdT or NK cells (2015) (15)
Differences in Epstein-Barr virus expression between primary and secondary cutaneous angiocentric lymphomas. French Study Group of Cutaneous Lymphomas. (1998) (15)
Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia. (1998) (15)
Nodal follicular helper T-cell lymphoma may present with different patterns. A case report. (2009) (15)
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study. (2017) (15)
Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment. (1988) (15)
Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay (2017) (15)
Rituximab in combination with CHOP regimen in angioimmunoblastic T-cell lymphoma: Results of the phase II RAIL trial--A prospective study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA). (2010) (15)
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders (2020) (15)
HHV8‐related non‐Hodgkin's lymphoma of the spermatic cord in a patient with HIV‐associated multicentric Castleman disease (2003) (14)
ROQUIN/RC3H1 Alterations Are Not Found in Angioimmunoblastic T-Cell Lymphoma (2013) (14)
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma. (2001) (14)
ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. (2020) (14)
Prostatic lymphoma of mucosa‐associated lymphoid tissue: an uncommon location (2002) (14)
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients. (2001) (14)
Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice (2016) (14)
Preferential localisation of human lymphocytes bearing y5 T cell receptors to the red pulp of the spleen. (14)
Peripheral neuropathy with distal nerve infiltration revealing a diffuse pleiomorphic malignant lymphoma (1987) (14)
New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP (2020) (14)
ALK is not expressed in Hodgkin disease. (2001) (13)
Anaplastic large cell lymphoma, ALK-positive and anaplastic large cell lymphoma ALK-negative (2009) (13)
Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression. (2017) (13)
Tricky and terrible T-cell tumors: these are thrilling times for testing: molecular pathology of peripheral T-cell lymphomas. (2011) (12)
Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma (2007) (12)
Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies (2018) (11)
EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas. (2020) (11)
Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma (2020) (11)
A Prospective Phase II Trial of An L-Asparaginase Containing Regimen in Patients with Refractory or Relapsing Extra Nodal NK/T-Cell Lymphoma (2008) (11)
Acute megakaryocytic leukemia (AMKL) with major myelofibrosis in an infant. Diagnosis by liver biopsy and response to treatment. (1991) (11)
[Acute mast cell leukemia disclosed by vasomotor flushing]. (1997) (11)
TiA1 in advanced-stage classical Hodgkin’s lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells (2004) (11)
Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study (2019) (11)
Constitutive STAT 6 activation in primary mediastinal large B-cell lymphoma (2004) (10)
Epidermotropic secondary cutaneous involvement by relapsed angioimmunoblastic T‐cell lymphoma mimicking mycosis fungoides: a case report (2012) (10)
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation (2021) (10)
Primary mucosa-associated lymphoid tissue lymphoma of the gallbladder: report of a case harboring API2/MALT1 gene fusion. (2009) (10)
Detection of gene fusion transcripts in Peripheral T-cell Lymphoma using a multiplexed targeted sequencing assay. (2021) (10)
Peripheral neuropathy, coagulopathy and nodular regenerative hyperplasia of the liver in a patient with multiple serologic auto‐antibody activities and IgM B‐cell lymphoma (1989) (10)
First-line therapy of T-cell lymphoma: Allogeneic or autologous transplantation for consolidation—Final results of the AATT study. (2019) (10)
Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression (2016) (9)
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2. (2008) (9)
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients (2021) (9)
[Nasal NK/T lymphoma. A case report]. (2003) (9)
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study (2016) (9)
Maladie de Kikuchi récidivante chez une patiente atteinte de lupus discoïde (2003) (9)
Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma (2021) (9)
Primary brain lymphoma cell turnover differs in patients with and without AIDS: relationships to bcl-2 expression and host cell reaction. (1999) (8)
DNA methylation profiling of hepatosplenic T-cell lymphoma (2018) (8)
Gene analysis in 18 cases of cutaneous lymphoid infiltrates of uncertain significance. (1995) (8)
Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas (2022) (8)
Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western Europe (2012) (8)
Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process? (2011) (8)
Lenalidomide in Combination with CHOP in Patients with Angioimmunoblastic T-Cell Lymphoma (AITL): Final Analysis of Clinical and Molecular Data of a Phase 2 Lysa Study (2018) (8)
HIV encephalitis‐like multinucleated giant cells in a nodal lymphoma in AIDS (1990) (8)
Nonepidermotropic cutaneous lymphomas. A histopathological and immunohistological study of 52 cases. (1994) (8)
Germinal Center Phenotype Determined by Immunohistochemistry on Tissue Microarray Does Not Correlate with Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy in the Randomized Trial LNH98-5. A GELA Study. (2007) (7)
Recurrent mutations of the STAT 6 DNA binding domain in primary mediastinal B-cell lymphoma (2009) (7)
[Primary lymphomas of the digestive tract. Therapeutic results of a series of 35 cases]. (1984) (7)
FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY (2019) (7)
ROCHOP study: A phase III randomized study of CHOP compared to romidepsin-CHOP in untreated peripheral T-cell lymphoma. (2013) (7)
Donor or recipient origin of post-transplantation lymphoproliferative disorders: evaluation by in situ hybridization. (1997) (7)
Constitutive IL-2 expression in HTLV-I-infected leukaemic T cell lines. (1991) (7)
Sub-Cutaneous Rituximab-Minichop Versus Sub-Cutaneous Rituximab-Minichop + Lenalidomide (R2-miniCHOP) in Diffuse Large B Cell Lymphoma for Patients of 80 Years Old or More (SENIOR Study). a Multicentric Randomized Phase III Study of the Lysa (2019) (7)
Rituximab in combination with CHOP regimen in T-cell angioimmunoblastic lymphoma (AILD-TL) rich in large B cells. Favourable results in four patients. (2004) (7)
Maladie de Hodgkin à prédominance lymphocytaire nodulaire ou type I (paragranulome de Poppema-Lennert): une entité anatomo-clinique.Etude de 21 cas et revue de la littérature. (2000) (7)
Prognostic Impact of Germinal Center (GC)/ Activated B-Cell (ABC) Classification Analysed by Immunochemistry, FISH Analysis and GEP, In Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The Bio-CORAL Study (2010) (7)
Peripheral T‐cell lymphoma in HIV‐infected patients: a study of 17 cases in the combination antiretroviral therapy era (2013) (7)
[Epstein-Barr virus: pathologic implications]. (1998) (7)
R-ACVBP Benefits to Younger Patients with Non-Germinal Centre Diffuse Large B-Cell Lymphoma As Compared to R-CHOP in the GELA Trial LNH03-2B (2011) (7)
Efficiency of In Vivo Purging With Rituximab Followed by High-Dose Therapy With Autologous Peripheral Blood Stem Cell Transplantation in B-Cell Non-Hodgkin’s Lymphomas: A Single-Institution Study (2001) (6)
Darier's sign in cutaneous large T-cell lymphoma. (1996) (6)
Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. (2001) (6)
Primary cutaneous aggressive epidermotropic CD8+ T‐cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier (2015) (6)
Interleukin 7 receptor expression in cutaneous T-cell lymphomas (1994) (6)
Characterization of Hodgkin's lymphoma-like undifferentiated carcinoma of the nasopharyngeal type as a particular UCNT subtype mimicking Hodgkin's lymphoma. (2003) (6)
Can peripheral T-cell lymphomas be morphologically subclassified? A morphometric approach to 21 cases. (1986) (6)
[T-cell lymphomas and "natural killer". Histopathologic, immunologic and molecular aspects]. (1998) (6)
Leucoencephalopathy with multinucleated giant cells containing human immune deficiency virus-like particles and multiple opportunistic cerebral infections in one patient with AIDS (2004) (6)
Bilateral tumoral infiltration of the Achilles tendons revealing chronic myelomonocytic leukemia. (1993) (6)
Sécuriser le diagnostic en anatomie et cytologie pathologiques en 2011. L’erreur diagnostique : entre discours et réalité (2011) (6)
Expression of the alpha beta and gamma delta T-cell receptors in peripheral T-cell lymphomas. (1990) (5)
Evaluation of a low density DNA microarray for small B-cell non-Hodgkin lymphoma differential diagnosis (2009) (5)
MYC Gene Simple Hit Is a Strong Independent Predictive Factor of Survival in Diffuse Large B-Cell Lymphomas in Contrast to MYC Double-Hit Gene Alterations: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte (2012) (5)
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome (2022) (5)
Definition of a minimal genes set for mature lymphoid blood diseases (2018) (5)
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. (2012) (5)
Follicular variant of peripheral T cell lymphoma with mediastinal involvement in a child: a case report (2015) (5)
A phase I study of IV aflibercept (Afl) in combination with R-CHOP in untreated patients (pts) with B-cell lymphoma. (2010) (5)
Erratum: The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas (British Journal of Haematology (2005) 128 (333-342)) (2005) (5)
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations (2022) (5)
GENE EXPRESSION PROFILING OF SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA REVEALS DIFFERENCES DEPENDING ON ALK STATUS AND TWO DISTINCT MORPHOLOGICAL ALK SUBTYPES (2006) (5)
Primary extranodal CD8 positive epitheliotropic T‐cell lymphoma arising in a leiomyoma of the uterus (2003) (4)
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV (2022) (4)
Deﬁning the signatures of peripheral T-cell lymphoma, with a targeted 20-markers gene expression proﬁling assay (RT-MLPA) (2019) (4)
Classification des lymphomes non hodgkiniens (2000) (4)
[Recurrent Kikuchi's disease in a patient with discoid lupus]. (2003) (4)
Activation of wild-type p53 by MDM2 inhibitors: a new strategy for lymphoma treatment (2015) (4)
Maladie de Hodgkin classique : biologie et formes frontières (2004) (4)
Recurrent Mutations of the Exportin 1 Gene (XPO1) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study (2015) (4)
Characteristics of Refractory and Relapsing Patients with Diffuse Large B-Cell Lymphoma. (2008) (4)
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients. (2001) (4)
HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY (2019) (4)
Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study (1996) (4)
[Unusual hepatic tumor]. (1999) (4)
Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey. (2022) (4)
Lymphoma : A Clinicopathologic Entity Associated With Peculiar Phenotype and With Epstein-Barr Virus (2003) (4)
Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study (1993) (4)
Autologous stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and overexpression of bcl2 protein. Results of the first interim analysis of the GELA trial LNH98-B2. (2004) (4)
Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The French Lymphoma Study Association (LYSA) registry data. (2018) (4)
Primary cutaneous peripheral T‐cell lymphomas with a T‐follicular helper phenotype: an integrative clinical, pathological and molecular case series study (2022) (4)
[CD30 (Ki-1+) anaplastic large cell lymphomas]. (1989) (3)
Early Response Evaluation with 18FDG-PET Scanning, but Not Phenotypic Profile, Are Predictive of Outcome in Diffuse Large B-Cell Lymphoma. (2005) (3)
[Hodgkin disease with nodular lymphocytic predominance or type I (paragranuloma of Poppema-Lennert): a clinico-pathological entity. Study of 21 cases and review of the literature]. (2000) (3)
Lymphomes non hodgkiniens. Aspects anatomocliniques (1998) (3)
VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers. (2017) (3)
Exclusive B‐cell phenotype of primary prostatic lymphomas: a potential role of chronic prostatitis (2019) (3)
Controversies in the Treatment of Peripheral T-cell Lymphoma (2020) (3)
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigentic reprogramming. (2021) (3)
Primary pulmonary large B‐cell lymphoma—mediastinal type? (2011) (3)
Multifocal polyclonal Epstein–Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab (2010) (3)
VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers (2017) (3)
Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood. (1992) (3)
The t(11;18)(q21;q21) characterizes a subgroup of extranodal MALT lymphomas: a two-color fluor-escence in situ hybridization study using AP12 and MLT specific probes (1999) (3)
Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study (2022) (3)
[Treatment of large-cell gastric lymphoma: comparison of the efficacy of radiochemotherapy alone or combined with first gastrectomy]. (1996) (3)
Ulcère de jambe lié à une cryoglobulinémie de type 1 révélant un lymphome B " incipiens " (2013) (3)
prospective Phase Ii Trial Of Lenalidomide In Association With Chop In Elderly Patients With Angioimmunoblastic T Cell Lymphoma (aitl): Interim Analysis Of A Lysa Study : 101 (2015) (3)
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop (2016) (3)
Extranodal T- and NK-cell lymphomas (2022) (3)
VIII. New markers in peripheral T‐cell lymphomas: more entities or more confusion? (2013) (2)
Lymphomes B diffus à grandes cellules : de la morphologie à la biologie (2006) (2)
[Securising diagnosis in pathology in 2011. The diagnostic error: between rhetoric and reality]. (2011) (2)
Virus epstein-barr et lymphomes T/NK : intérêt physiopathologique et pratique (2001) (2)
A New Immunohistochemical Algorithm Using Four Antibodies Has a High Concordance with Gene Expression Profiling Defined ABC and GCB Diffuse Large B-Cell Lymphoma (2017) (2)
T Cell Receptor Variable Region Gene Expression in Cutaneous T-Cell Lymphoma (1994) (2)
Failure of Combination Chemotherapy of Advanced Follicular (Low‐Grade) Non‐Hodgkin's Lymphoma (1987) (2)
[Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma]. (2015) (2)
T Lymphoblastic Lymphoma (T-LL): One or Two Diseases?. (2005) (2)
Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation (2022) (2)
Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study (2021) (2)
[Leg ulcer associated with type I cryoglobulinaemia due to incipient B-cell lymphoma]. (2013) (2)
des Lymphomes de l'Adulte (GELA) trials angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude Clinical, biologic, and pathologic features in 157 patients with (2013) (2)
MYC+ Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report (2011) (2)
Gene Expression Profile Associated with Survival in Patients with Diffuse Large B-Cell Lymphoma Treated by Chemotherapy and Rituximab. (2005) (2)
Progressive hemispheric atrophy in HIV: A Rasmussen's‐like variant of CD8 encephalitis? (2022) (2)
Effect of expression of ICOS in cutaneous T-cell lymphoma and its targeting on killing of malignant cells. (2020) (2)
Clinicopathologic Characterization of Cyclin D1-Negative Mantle Cell Lymphoma (2012) (2)
Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (2021) (2)
Du neuf dans l’oncogenèse moléculaire des lymphomes : rôle du gène SETD2 dans les lymphomes T de l’intestin (2017) (2)
ACTIVATION OF RHOA‐VAV1 SIGNALING IN ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA (2017) (2)
Aspects moléculaires des lymphomes T périphériques (1) - Lymphome T angio-immunoblastique, lymphome T périphérique non spécifié et lymphome anaplasique à grandes cellules (2015) (2)
The Gene Expression Profile of Nodal T-Cell Lymphomas Identifies a Molecular Link between Angioimmunoblastic T-Cell Lymphoma (AITL) and Follicular Helper T Cells (TFH), and between CD30+ Peripheral T-Cell Lymphoma and ALK-Negative Anaplastic Large Cell Lymphoma (ALCL). (2006) (2)
Recurrent TET2 mutations in adult T cell leukemia (2014) (2)
Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The French Lymphoma Study Association (LYSA) Registry Data (2018) (2)
Angioimmunoblastic T-Cell Lymphoma: A Clinicopathologic Study of 158 Patients Treated in GELA (Groupe d’ Etude des Lymphomes de l’ Adulte) Trials. (2006) (2)
Lymphomes hodgkiniens et formes frontières (2002) (2)
CD3‐T cell receptor modulation is selectively induced in CD8 but not CD4 lymphocytes cultured in agar (1990) (2)
Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study (2021) (2)
Angioimmunoblastic T-cell lymphoma: a tumor of follicular helper T cells derivation with clinical and pathological relevance (2009) (1)
KIR3DL2 contributes to the typing of acute-type adult T-cell leukemia and is a potential therapeutic target. (2022) (1)
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study. (2022) (1)
mantle cell lymphoma - D1 CCND2 rearrangements are the most frequent genetic events in cyclin (2013) (1)
PD1 in Sézary syndrome: a repressor of cell survival sometimes lost during progression, but a new target using depleting antibodies? (2021) (1)
Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial" (2020) (1)
New Insights into the Molecular Pathogenesis of T-Cell Lymphomas (2019) (1)
IMPACT OF DUSP22 REARRANGEMENT ON THE PROGNOSIS OF SYSTEMIC ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A LYSA AND TENOMIC STUDY (2021) (1)
Protein Tyrosine Phosphatase Type-1 (PTPN1) Is Frequently Mutated In Primary Mediastinal B Cell Lymphoma and Hodgkin Lymphoma (2013) (1)
Final Analysis of the International Double-Blind Randomized Phase III Study of Lenalidomide Maintenance in Elderly Patients with DLBCL in Response after R-CHOP, the Remarc Study from Lysa (2020) (1)
Diffuse Large B-Cell Lymphomas of the Waldeyer’s Ring Frequently Have a Germinal Center-Like Phenotype: A Clinico-Pathological Study of 209 Patients from the Groupe d’Etude des Lymphomes de L’Adulte (GELA). (2007) (1)
Les lymphomes anaplasiques à grandes cellules associés aux prothèses mammaires : du diagnostic au séquençage moléculaire (2020) (1)
Peripheral T-Cell Lymphomas with Follicular Growth Patterns Are Derived from Follicular Helper T Cells (TFH): A Link with Angioimmunoblastic T-Cell Lymphomas?. (2007) (1)
Other peripheral T cell lymphomas: pathology and molecular pathogenesis (2010) (1)
[Non-Hodgkin's lymphoma in HIV infection. A multicenter retrospective study of 21 cases]. (1990) (1)
Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression. (2020) (1)
Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma (2022) (1)
Brentuximab Vedotin in refractory or relapsed Peripheral T-cell Lymphoma: The French name patient program experience in 66 patients (2015) (1)
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality (2022) (1)
Correlation between RNA and protein levels in a large european series from the LYSA (2013) (1)
Mature T-cell lymphomas (2015) (1)
[Gamma-delta T-cell lymphoma: outcome of a hyperactive malarial splenomegaly?]. (2009) (1)
Frequent Activating Mutations Of JAK-STAT Pathway Genes In Natural Killer Cell Lymphomas (2013) (1)
Combining Gene Expression Profiling and Artificial Intelligence to Diagnose B-Cell Non-Hodgkin Lymphoma (2019) (1)
Session 4 : lymphoma genomics (2011) (1)
Polymerase chain reaction (PCR) amplification demonstrates the absence of human T-cell lymphotrophic virus (HTLV)-I specific pol sequences in peripheral T-cell lymphomas (1990) (1)
Percutaneous Fine Needle Aspiration Cytology and Biopsy in the Diagnosis and Classification of Lymphoma: Clinical Evaluation. (1991) (1)
Pièges et nouveautés en hématopathologie. Introduction et résumé des principaux messages (2012) (1)
MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT (2021) (1)
Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET 2 expression (2017) (1)
ROQUIN / RC 3 H 1 alterations are not found in angioimmunoblastic T-cell lymphoma (2018) (1)
The EHA Research Roadmap: Malignant Lymphoid Diseases (2022) (1)
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment. (2023) (1)
Primary Nasal NK/T Cell Lymphoma: Cytology and Level of the Antiapoptotic PI9 Protein Have Prognostic Relevance. (2004) (1)
[Molecular pathogenesis of peripheral T cell lymphoma (2): extranodal NK/T cell lymphoma, nasal type, adult T cell leukemia/lymphoma and enteropathy associated T cell lymphoma]. (2015) (1)
Expert central review in lymphoma diagnosis. Is there a need? (2017) (1)
Cutaneous lesions in angiocentric T-cell lymphoma. Immunological, virological and genotypic studies (1993) (1)
Pathobiology of Peripheral T-Cell Lymphomas (2014) (1)
PD‐1 BLOCKADE IN A FRENCH SERIES OF 13 RELAPSED / REFRACTORY NK/T‐CELL LYMPHOMA PATIENTS (2019) (1)
BONE MARROW INVOLVEMENT, BUT NO BLOOD INVOLVEMENT, IMPAIRS SURVIVAL IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: AN ANCILLARY STUDY OF THE REVAIL TRIAL (2019) (1)
Influence of translocation t(11;18) on response to conservative treatment of MALT gastric lymphoma (MGL) (2003) (1)
Array CGH Analysis of Nodal T-Cell Lymphomas: Identification of Genomic Alterations Specific to Angioimmunoblastic and Unspecified Subtypes, and Correlation with Transcriptomic Data. (2007) (1)
[Classical Hodgkin's lymphoma: biology and grey zones]. (2004) (1)
LYMPHOID NEOPLASIA CD 10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells (2015) (1)
[Pitfalls and update in haematopathology. Conclusion]. (2012) (1)
T-Cell/Histiocyt e-Rich L arge B -Cell L ymphomas a nd C lassical Diffuse L arge B -Cell L ymphomas H ave S imilar O utcome A fter Chemotherapy: A M atched-Control A nalysis (2003) (1)
Lymphomes T cutanés non classables à différenciation TFH : à propos de six cas illustrant de nouveaux aspects anatomocliniques (2012) (1)
Aspects moléculaires des lymphomes T périphériques (2) - Lymphome NK/T extra-ganglionnaire de type nasal, leucémie/lymphome T de l’adulte HTLV-1+, lymphome T associé à une entéropathie (2015) (1)
Pièges et nouveautés en hématopathologie. Conclusion (2012) (1)
ICOS est fortement exprimé dans les lymphomes T cutanés épidermotropes et son ciblage permet l’inhibition des cellules tumorales (2020) (1)
Analysis of the intraclonal diversity of HLA‐A0201‐restricted T lymphocyte epitopes in follicular lymphoma idiotype (2005) (1)
Anaplastic large cell lymphomas associated with breast implants: from diagnosis to molecular sequencing (2020) (0)
The Peripheral T‐Cell Lymphomas (2014) (0)
Involvement of STAT3 Transcription Factor in Disseminated Nasal-Type Natural Killer Cell Lymphomas. (2007) (0)
Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma (2013) (0)
Lymphome T cutané primitif épidermotrope agressif CD8+ avec expression de KIR3DL2 : à propos de deux cas (2014) (0)
Lymphome T périphérique d'architecture folliculaire (2008) (0)
P.189 Réponse des lymphomes gastriques B diffus à grandes cellules au traitement éradicateur de Helicobacter pylori : à propos de 7 cas (2009) (0)
Chromatin Accessibility Profiling to Increase Diagnostic Accuracy and Refine Cell-of-Origin Classification of Mature T-Cell Lymphomas (2021) (0)
CD56 lymphomas. (1996) (0)
lymphomas Prognostic significance of survivin expression in diffuse large B-cell (2013) (0)
with T FH -like features and adverse clinical parameters (2016) (0)
273 THE SPECTRUM OF MUSCLE AND NERVE VASCULITIS IN AIDS (1990) (0)
Single-Cell and Spatial Analyses Characterize Distinct Subsets of Malignant T Cells in Angioimmunoblastic T Cell Lymphoma (2021) (0)
Announcements (1964) (0)
Conservative treatment of primary gastric B-cell lymphoma of MALT-type arising in the setting of HIV infection and posttransplantation (2001) (0)
Dualchip human low grade B-cell lymphoma: a specialized low density DNA microarray for the differential diagnostic of small B-cell non-Hodgkin's lymphoma (2005) (0)
Molecular mechanisms underlying transformation of large granular lymphocytic leukemia to high-grade T-cell lymphoma. (2023) (0)
A Molecular Classifier Increased the Accuracy of Lymphoma Diagnosis By Expert Pathologists in the Diffuse Large B-Cell Lymphoma Gained Trial from the Lysa (2021) (0)
Interphase fish study of hepatosplenic gamma/delta T-cll lymphoma (1999) (0)
Interleukin 4 -induced gene 1 ( FIG1 ) is activated in primary mediastinal large B cell lymphoma Short running head : FIG1 gene activation in PMBL (2002) (0)
The diversity of p53/p21 transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-cell lymphoma (DLBCL) (2007) (0)
Pseudo-lymphome à l'Atrium® à type de LMNH T pléiomorphe à moyennes et grandes cellules (1998) (0)
Lack of Reproducibility of Histopathological Features in MYC-rearranged Large B-cell Lymphoma Using Digital Whole Slide Images: A Study from the Lunenburg Lymphoma Biomarker Consortium. (2023) (0)
Lymphomes T périphériques : corrélations cliniques des sous-types histologiques et traitement (1999) (0)
Paper 81946 abstract 160359 0 (2015) (0)
LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: a LYSA STUDY (2017) (0)
F OLLICULAR HELPER T- CELLS : IMPLICATIONS IN NEOPLASTIC HAEMATOPATHOLOGY (2011) (0)
[Diffuse large cell B lymphoma: from morphology to biology]. (2006) (0)
MLT/MALT1 involving translocations and amplifications are important mechanisms in the pathogenesis of non-Hodgkin’s lymphoma (2005) (0)
Acknowledgement to Referees (2005) (0)
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]. (2021) (0)
Conservative treatment is suitable in patients with high-grade gastric lymphoma (1995) (0)
Intérêt des Tumorothèques pour la recherche et le diagnostic des lymphomes (2007) (0)
EBV associated « systemic » NK cell lymphoma, with hemophagocytosis (1999) (0)
tablissement dune classification molculaire des lymphomes T priphriques par cDNA-array (2004) (0)
La classification OMS des lymphomes et son avenir (2003) (0)
[Corneal crystalline deposits in benign monoclonal gammopathies. Apropos of 3 cases]. (1993) (0)
Nivolumab in Combination with Gemcitabine and Oxaliplatin (GemOx) in Relapse/Refractory T-Cell Lymphoma: Preliminary Results of the Experimental Arm of the Niveau Trial (2020) (0)
Breast Implant Associated-Anaplastic Large-Cell Lymphoma (BIA-ALCL): Data Based on the Lymphoma Study Association (LYSA) Registry. Promising Results of Brentuximab Vedotin Combined with Cyclophosphamide, Doxorubicin and Prednisone (BV-CHP) As First Line Treatment for Patient Requiring Chemotherapy (2021) (0)
Diffuse large B-cell lymphoma (DLBCL) of the waldeyer'ring (WR) frequently have a GC-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). (2008) (0)
Hairy cell leukemia hcl associated with large granular hyperlymphocytosis lgl immunological and genomic study effect of interferon therapy (1986) (0)
Impact des algorithmes du Groupe Français d’Étude des Lymphomes Cutanés sur le diagnostic anatomopathologique des lymphoproliférations cutanées (2020) (0)
[Unusual urinary bladder polyps]. (2002) (0)
Detection of the t(11;18)(q21;q21) on frozen and paraffin-embedded tissue using interphase FISH with API2 and MLT specific probes (2000) (0)
Distinct Expression Patterns of microRNAs in Activated B Cell (ABC) and Germinal Center B (GC) Subtypes of Diffuse Large B Cell Lymphoma (DLBLC). (2007) (0)
Une nouvelle « real » classification des lymphomes (1995) (0)
Analysis of a safety run-in cohort from NIVEAU, a phase 3 study for patients with aggressive Non-Hodgkin lymphoma in first relapse or progression not eligible for High-Dose Chemotherapy (HDT) testing Nivolumab in combination with (R)-GemOx (2020) (0)
ALK+ subtypes reveals differences based on ALK status and two distinct morphologic Gene-expression profiling of systemic anaplastic large-cell lymphoma (2013) (0)
Recurrent mutations in TET2, IDH2 and DNMT3 genes regulating DNA methylation in Peripheral T-cell Lymphomas correlate with TFH-like features and clinical parameters(LYS006) (2012) (0)
Désescalade thérapeutique dans les syndromes lymphoprolifératifs cutanés CD30 (2000) (0)
Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data (2019) (0)
[Physiopathology of Hodgkin's disease]. (1998) (0)
Number of Circulating t(14;18) Tumor Cells at Diagnosis Is Related to, but Add to the Prognostic Value of Metabolic Tumor Burden in Follicular Lymphoma (2015) (0)
Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection (2022) (0)
Maladie de Hodgkin à prédominance lymphocytaire nodulaire ou type I (paragranulome de Poppema-Lennert) : une entité anatomo-clinique (2008) (0)
Short Communication Regulatory T-Cell Depletion in Angioimmunoblastic T-Cell Lymphoma (2010) (0)
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T‐cell lymphoma: A French retrospective study (2023) (0)
Reactive and Neoplastic Large Granular Cell Proliferations in Blood and Bone Marrow (2013) (0)
Human Vδ1+ γδ Peripheral T-Cell Lymphoma/Leukemia are Derived from Natural Killer T (NKT) Cells and Might be Treated with Blocking Anti-CD1d Antibody (2016) (0)
Incidence and Risk Factors for Central Nervous System Relapse in Very Elderly Patients over 80 with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of Two Lysa Studies (2016) (0)
LYMPHOID NEOPLASIA CCND2 rearrangements are the most frequent genetic events in cyclin D1 (cid:1) mantle cell lymphoma (2013) (0)
Classification des lymphomes non hodgkiniens : Lymphomes non hodgkiniens (2000) (0)
Lymphome T gamma-delta : complication possible d’une splénomégalie palustre hyperactive ? (2008) (0)
Serum 2-Hydroxyglutarate in Angioimmunoblastic T Cell Lymphomas: A New Marker for IDH2 Mutation Detection and Monitoring (2018) (0)
ICOSL : un nouveau marqueur diagnostique et une nouvelle cible thérapeutique par utilisation d’une construction ICOS-Fc dans le syndrome de Sézary ? (2022) (0)
CLINICAL, IMMUNOPHENOTYPIC AND GENETIC CHARACTERISTICS OF AGGRESSIVE (NON‐BURKITT) B‐CELL LYMPHOMA IN A REAL LIFE COHORT (2019) (0)
CO.119 Résultats à long terme du traitement du lymphome gastrique du MALT par éradication de H. pylori et/ou chlorambucil ± rituximab (2009) (0)
Associated Multicentric Castleman ' s Disease − Human Herpesvirus 8 Infection in Patients With POEMS Syndrome (1999) (0)
Expression de KIR3DL2 dans les lymphomes T périphériques cutanés, extra-cutanés et ganglionnaires (2013) (0)
IN9 Pathology and pathophysiology of peripheral T-cell lymphomas (2012) (0)
Une tumeur sous-cutanée chez un jeune homme (2005) (0)
Complete remission of agranulocytosis after splenectomy in a variant form of T-cell large granular lymphocyte leukemia (2018) (0)
[Mid-face malignant T-cell lymphoma (old malignant granuloma). A series of 4 cases with immunophenotyping and genotype study]. (1992) (0)
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA. (2022) (0)
Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity. (2012) (0)
lymphoproliferative disorders: a study of 87 cases Comparison of genetic probe with immunophenotype analysis in (2011) (0)
Histology of Lymphomas with t(3;14)(q27;q32) Correlates with the Molecular Anatomy of the Translocation. (2005) (0)
[Non-Hodgkin's lymphoma. Aspects of clinical pathology]. (1998) (0)
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma (2022) (0)
Peripheral T / Nk Cell Lymphoma Clinic and Therapy (2004) (0)
Functional plasticity and recurrent cell states of malignant B cells in follicular lymphoma (2022) (0)
Molecular and Clinical Aspects of Angioimmunoblastic T-Cell Lymphoma (2013) (0)
PET Evaluation Before Autografting Has a Strong Prognostic Impact in High-Risk, Relapsed Follicular Lymphoma Patients (2011) (0)
Diagnostic des hémopathies malignes : analyse rétrospective des discordances entre histologie et cytométrie en flux sur une série de 339 cas au centre François-Baclesse (2011) (0)
ROLE OF UP‐FRONT AUTOLOGOUS STEM CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMAS: a PROPENSITY SCORE MATCHING ANALYSIS OF PATIENTS FROM LYSA CENTERS (2017) (0)
[Molecular oncogenesis of lymphomas: role of the SETD2 gene in intestinal T-cell lymphomas]. (2017) (0)
94 T and NK Cell Lymphomas (2004) (0)
Nasal T - c e l l Lymphoma: A Clinicopathologic Entity Associated With Peculiar Phenotype and With Epstein-Barr Virus (2003) (0)
MOLECULAR FEATURES OF HEPATOSPLENIC T-CELL POTENTIAL NOVEL THERAPEUTIC TARGETS (2012) (0)
Estimating the impact of rituximab on bcl-2-associated resistance to CHOP using competing risks in elderly patients with diffuse large B-cell lymphoma (DLBCL). (2006) (0)
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK‐cell counts in rituximab–chemotherapy responsive elderly DLBCL patients: A LYSA group study (2023) (0)
David York Mason (1941-2008). Antibody wizard and a founder of modern hemopathology (2008) (0)
Mechanisms of T‐cell Lymphomagenesis (2021) (0)
Global Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes In Natural Killer Cell Lymphomas (2013) (0)
SERUM 2‐HYDROXYGLUTARATE, A PREDICTIVE BIOMARKER OF THE PRESENCE OF IDH2 MUTATIONS IN AITL PATIENTS (2017) (0)
[A subcutaneous tumor in a young man]. (2005) (0)
PS1303 CHRONIC TCR STIMULATION PROMOTES PERIPHERAL T-CELL LYMPHOMAGENESIS AND INDUCES ADDICTION TO SYK AND NK RECEPTOR SIGNALING (2019) (0)
Le profil d’expression génique des lymphomes T angio-immunoblastiques diffè de celui des lymphomes T périphériques sans spécificité et présente des analogies avec celui des cellules T Helper folliculaires(TFH) (2006) (0)
Lymphome NK/T nasal (2008) (0)
Overt B-cell non-Hodgkin's lymphoma (B-NHL): Role of hepatitis C virus (HCV) (2000) (0)
THIRTY YEARS OF T‐CELL LYMPHOMAS (2019) (0)
Peripheral T-Cell Lymphoma, Not Otherwise Specified (2019) (0)
Caractérisation des cellules tumorales exprimant CXCL13 dans les lésions cutanées de lymphomas T type LAI (2006) (0)
Hepatosplenic γδ T-cell Lymphoma is a Rare Clinicopathologic Entity with Poor Outcome : Report on a Series of 21 Cases . Short title : HEPATOSPLENIC γδ T-CELL LYMPHOMA (2003) (0)
Analyses of chromosomal abnormalities involving the MLT/MALT1 gene in marginal zone B-cell lymphoma using a novel interphase FISH assay (2003) (0)
Reply to M. Romero et al. (2020) (0)
Integrative Study of a High-Grade B-Cell Lymphoma Cohort of 45 Patients: A Single Institution Real Life Study (2021) (0)
‘ ‘ focus on . . . ’ ’ session : primary mediastinal and other extranodal lymphoma (2008) (0)
REFINEMENT OF MUM1 EXPRESSION THRESHOLD FOR DOUBLE POSITIVE CD10+ MUM1+ DIFFUSE LARGE B CELL LYMPHOMA ALLOWS A BETTER CELL OF ORIGIN CLASSIFICATION FOR GCB SUBTYPE (2019) (0)
BCL2 Negative Follicular Lymphoma with BCL6 Gene Rearrangement Show Mutations of STAT6 DNA Binding Domain (2012) (0)
Epstein-Barr Virus: Main Pathogenic Agent in Hodgkin Lymphoma Associated Hemophagocytic Syndrome?. (2007) (0)
MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA (2019) (0)
Surgery plus chemotherapy or chemotherapy alone for localized high-grade gastric lymphomas (2000) (0)
Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS Category (2016) (0)
Biology of T‐Cell Lymphoma: FR‐S24‐NHL‐050 (2018) (0)
The microenvironment in T-cell lymphomas (2015) (0)
Pr Bertrand Coiffier (2019) (0)
l'Adulte (GELA) non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de Prognostic significance of bcl-2 protein expression in aggressive (2002) (0)
[Cutaneous lymphomas: expert review or diagnostic algorithms?]. (2015) (0)
Molecular Characterisation of Diffuse Large B Cell Lymphoma in Patients of 80 Years Old or More: Clinical Relevance in a Multicentric Randomized Phase III Study of the Lysa (SENIOR Study) (2019) (0)
Clinical Spectrum, Evolution and Management of Autoimmune Cytopenia Associated with Angioimmunoblastic T-Cell Lymphoma: A Retrospective, Multicenter Study (2016) (0)
Clinical, Immunophenotypic and Genetic Characteristics of Aggressive (non-Burkitt) B-Cell Lymphoma in a Real Life Cohort (2019) (0)
The usefulness of phenotypic and genotypic studies in malignant lymphoma and related disorders. (1989) (0)
Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial" (2022) (0)
First Lymphoma Study Association workshops Deauville (France), 10th-12th October 2013 – part 2 (2014) (0)
Eosinophilic Dysplasia of the Cervix: Which Are the Invasive and Cytologic Counterparts? (2005) (0)
[Intrasinusal bone marrow lymphoid infiltration]. (2002) (0)
NUP98-HOXA9-Initiates Molecular and Biologic Features of Disease Progression in a Humanized Model of CML (2019) (0)
Lymphome du MALT thymique dans un contexte dysimmunitaire de type Sjögren avec transformation en lymphome B de haut grade (2008) (0)
Caractérisation histologique des présentations cutanées des lymphomes T angio-immunoblastiques (2011) (0)
Lymphome NK « systémique » associé à l’EBV, révélé par un syndrome hémophagocytaire (1999) (0)
Expression et régulation de l’expression de PD-1 et ses ligands PD-L1/2 dans les cellules néoplasiques du syndrome de Sézary et leur environnement (2013) (0)
Les lymphomes diffus a grandes cellules B (LDGCB) à présentation amygdalienne ont fréquemment un phénotype « germinal center-like » : une étude clinicopathologique de 209 patients du groupe d’étude des lymphomes de l’adulte (GELA) (2006) (0)
Les lymphomes T angio-immunoblastiques (LAI) ont un phénotype CD4+/CD10+/Bcl6+ et expriment fréquemment les facteurs de transcription MUM1, OCT2 et son co-activateur BOB1 (2008) (0)
Lymphome malin T centrofacial (ancien granulome malin) : une série de quatre cas avec étude immunophénotypique et génotypique (1992) (0)
Le lymphome T angio-immunoblastique : une étude anatomo-clinique d’une série de 158 patients inclus dans les protocoles du GELA (Groupe d’étude des lymphomes de l’adulte) (2006) (0)
Présence de réarrangement de BCL2 avec surexpression de Bcl-2 dans une série de lymphomes centrofolliculaires cutanés primitifs (2011) (0)
Identification of Previously Unrecognized CD1d-Restricted Peripheral T Cell Lymphomas (PTCLs) in Mouse and Human Reveals Blocking Anti-CD1d Monoclonal Antibodies As a New Therapeutic Possibility in PTCLs (2014) (0)
Relecture centralisée du diagnostic histopathologique de lymphome. Résultats et perspectives d’une étude nationale à grande échelle (2018) (0)
dendritic cells that inhibits T-lymphocyte proliferation Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature (2013) (0)
Communications orales de la SFP (Hématologie, Néphrologie, ORL, Pneumologie, Techniques) - Le profil de type centre germinatif en immunohistochimie sur tissue-micro-array présente une bonne corrélation avec la classification moléculaire et représente un facteur pronostique favorable dans les lymphom (2008) (0)
Communications orales du GPCM - Le profil d’expression génique des lymphomes T angio-immunoblastiques diffère de celui des lymphomes T périphériques sans spécificité et présente des analogies avec celui des cellules T Helper folliculaires (TFH) (2008) (0)
Leucémie à tricholeucocytes : une hémopathie particulière associée à des mutations récurrentes de BRAF BRAF mutation in hairy cell leukemia (2012) (0)
PD1 dans le syndrome de Sézary : un répresseur de la survie cellulaire parfois perdu lors de la progression tumorale mais une nouvelle cible thérapeutique par approche déplétante ? (2020) (0)
Caractéristiques des lymphomes à cellules T/NK après transplantation rénale : une étude rétrospective multicentrique nationale française (2019) (0)
Le profil de type centre germinatif en immunohistochimie sur tissue-micro-array présente une bonne corrélation avec la classification moléculaire et représente un facteur pronostique favorable dans les lymphomes diffus à grandes cellules B traités par CHOP ou CHOP+ anti-CD20 (2006) (0)
Premières Journées de la Lymphoma Study AssociationDeauville, 10-12 octobre 2013Partie 2 (2014) (0)
Decision letter: Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking (2021) (0)
Caractéristiques cliniques, évolution et prise en charge des cytopénies auto-immunes associées aux lymphomes T de type LAI : une étude multicentrique rétrospective comparative (2016) (0)
ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells. (2021) (0)
-like features and adverse clinical parameters FH T mutations in peripheral T-cell lymphomas correlate with TET2 Recurrent (2013) (0)
Lymphomes cutanés : double lecture ou algorithmes diagnostiques ? (2015) (0)
Kir3dl2 : biomarqueur et cible thérapeutique utile pour respectivement prévenir et traiter un sous-ensemble de lymphomes t cutanés et non cutanés périphériques (2014) (0)
Impact des algorithmes du groupe français d’étude des lymphomes cutanés (GFELC) sur le diagnostic anatomopathologique des lymphoproliférations cutanées (2021) (0)
Appendix : List of the participants to the Tenomic consortium belonging to the centers of the Groupe d ' Etude des Lymphomes de l ' Adulte ( GELA ) and Groupe Ouest Est des Leucémies et Autres Maladies (2012) (0)
Hodgkin's lymphoma and grey zones (2002) (0)
[Impact of algorithms proposed by the Cutaneous Lymphoma French Study Group for diagnosis of cutaneous lymphoproliferations]. (2021) (0)
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment (2023) (0)
Early relapses and failure to achieve complete remission are the main prognostic factors in CD20 diffuse large B-cell lymphoma (DLBCL) treated with R-ICE or R-DHAP followed by stem cell transplantation in the CORAL study : 218 (2008) (0)
FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T cell lymphoma, not otherwise specified (2021) (0)
Lymphome folliculaire primitif du duodénum (2005) (0)
Misleading Features of Bone Marrow Involvement by Peripheral T-Cell Lymphomas (2012) (0)
Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma (2020) (0)
CD30 expression in peripheral T-cell lymphomas, not otherwise specified: is it relevant for the identification of distinct subgroups?(LYS011) (2012) (0)
The word of the President! (2012) (0)
Caractérisation morphologique, phénotypique et moléculaire des infiltrats cutanés survenant au cours du lymphome T angio-immunoblastique : mise en évidence de la mutation RHOA p.G17 V in situ☆ (2015) (0)
CeVi: A UNIQUE CRYOPRESERVED HUMAN VIABLE CELL COLLECTION FROM LYMPHOMA PATIENTS, A CALYM INITIATIVE TO ACCELERATE INNOVATION AND ITS TRANSFER TO LYMPHOMA FIELD (2019) (0)
Association of low expression of VEGF121 soluble isoform with prognostic impact and survival in patients with activated B-cell-like (ABC-like) diffuse large B-cell lymphoma (DLBCL) from the CORAL trial. (2012) (0)
KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET (2019) (0)
Classification of diffuse large b-cell lymphoma (DLBCL) FFPE samples of the GELA LNH2003 program, using Lymph2Cx assay on the nCounter analysis system. (2016) (0)
The Distinct Molecular Signature Of Hepatosplenic T-Cell Lymphoma (Hstl) Identifies Oncogenic Pathways With Potential Therapeutic Relevance (2011) (0)
[Follicular lymphomas: function and expression of bcl-2 gene]. (1993) (0)
PATHOLOGY OF MUSCLE IN TRICHINOSIS: A SERIES OF 18 CASES (1989) (0)
Recurrent TET2 mutations in adult T cell leukemia (2014) (0)
GENE EXPRESSION PROFILING USING a RTMLPA ASSAY ALLOWS FOR AN ACCURATE CLASSIFICATION OF PERIPHERAL T‐CELL LYMPHOMA AND HIGHLIGHTS NOVEL SUBGROUPS WITHIN PTCLS‐NOS (2017) (0)
Erratum (2005) (0)
[Pitfalls and update in haematopathology. Introduction and summary of the main take home messages]. (2012) (0)
Increased expression of interleukina during liver al&raft rejection (1999) (0)
Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort. (2023) (0)
BASELINE CIRCULATING TUMOUR DNA AND TOTAL METABOLIC TUMOUR VOLUME AS EARLY OUTCOME PREDICTORS IN AGGRESSIVE B‐CELL LYMPHOMA. A REAL LIFE PROSPECTIVE 112‐PATIENT COHORT (2021) (0)
Monochemotheray as treatment of low-grade B-cell gastric mucosa associated lymphoid tissue lymphoma (1995) (0)
INTEGRATIVE ANALYSIS OF FEATURES ASSOCIATED WITH TET2, IDH2, DNMT3A, AND RHOA MUTATIONS IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: A LYSA STUDY (2017) (0)
JAK‐STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLAYERS IN BI‐ALCL PATHOGENESIS? (2019) (0)
Scientific category: Lymphoid neoplasia Title: Indolent T-cell lymphoproliferative disease of the gastrointestinal tract Authors: (2013) (0)
Lymphome malin non Hodgkinien agressif à cellules T compliquant une LLC : un inhabituel syndrome de Richter (2006) (0)
or R-DHAP followed by BEAM plus autologous stem cell transplantation diffuse large B-cell lymphoma is not salvaged by classical R-ICE + MYC (2012) (0)
Expression of the Alpha/Beta and Gamma/ Delta T-cell Receptors in 57 Cases of Peripheral T-cell Lymphomas Identification of a Subset of y/6 T-ceII Lymphomas (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Philippe Gaulard?

Philippe Gaulard is affiliated with the following schools:

Philippe Gaulard's Academic­Influence.com Rankings

Philippe Gaulard's Degrees

Why Is Philippe Gaulard Influential?

Philippe Gaulard's Published Works

Published Works

What Schools Are Affiliated With Philippe Gaulard?

Philippe Gaulard's AcademicInfluence.com Rankings